TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Abroad (travel likely)RecruitingPHASE1

Conditions

Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Arizona Oncology Associates, Tucson, Arizona, United States

  • University of Southern California, Los Angeles, California, United States

  • Hoag Memorial Hospital, Newport Beach, California, United States

  • Rocky Mountain Cancer Centers, Denver, Colorado, United States

    Study coordinator · 303-388-4876
  • Yale Cancer Center, New Haven, Connecticut, United States

  • Christiana Care Helen F. Graham Cancer Center, Newark, Delaware, United States

  • John Hopkins Kimmer Cancer Center, Washington D.C., District of Columbia, United States

  • Florida Cancer Specialists, Daytona Beach, Florida, United States

    Study coordinator · 386-231-4060
  • Florida Cancer Specialists, Fleming Island, Florida, United States

  • Ocala Oncology Center, Ocala, Florida, United States

    Study coordinator · 352-547-1958
  • AdventHealth Research Institute, Orlando, Florida, United States

  • Illinois Cancer Specialists, Arlington Heights, Illinois, United States

  • University of Illinois, Chicago, Illinois, United States

  • Indiana University, Indianapolis, Indiana, United States

  • Norton Cancer Institute, Louisville, Kentucky, United States

  • American Oncology Partners, P.A. - The Center for Cancer & Blood Disorders, Bethesda, Maryland, United States

    Study coordinator · 301-571-2016
  • Maryland Oncology Hematology, Silver Spring, Maryland, United States

    Study coordinator · 301-933-3216
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • START Midwest, Grand Rapids, Michigan, United States

    Study coordinator · 616-954-5554
  • Regions Hospital Cancer Care Center, Saint Paul, Minnesota, United States

    Study coordinator · 651-254-3602
  • Washington University in St Louis, St Louis, Missouri, United States

  • Nebraska Cancer Center Oncology Hematology West P.C., Omaha, Nebraska, United States

    Study coordinator · 402-691-6971
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Study coordinator · 732-235-3253
  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Stony Brook University, Stony Brook, New York, United States

  • University of Cincinnati, Cincinnati, Ohio, United States

    Study coordinator · 513-584-5680
  • Zangmeister Cancer Center, Columbus, Ohio, United States

  • The University of Toledo, Toledo, Ohio, United States

  • University of Oklahoma, Oklahoma City, Oklahoma, United States

    Study coordinator · 405-271-8001
  • University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina, Charleston, South Carolina, United States

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

    Study coordinator · 615-524-4203
  • Vanderbilt - Ingram Cancer Center, Nashville, Tennessee, United States

  • Texas Oncology - Dallas, Dallas, Texas, United States

    Study coordinator · 214-370-1000
  • START Dallas, Fort Worth, Texas, United States

    Study coordinator · 682-350-3010
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Texas Oncology - Paris, Paris, Texas, United States

    Study coordinator · 903-785-0031
  • NEXT Oncology, San Antonio, Texas, United States

  • NEXT Oncology Virginia, Fairfax, Virginia, United States

    Study coordinator · 703-280-5290
  • Northwest Medical Specialties, Tacoma, Washington, United States

  • Northwest Cancer Specialists, Vancouver, Washington, United States